GO
Loading...

Boston Scientific Corp

More

  • Final Glance: Medical Devices companies Wednesday, 23 Apr 2014 | 6:04 PM ET

    Allergan rose $2.00 or 1.2 percent, to $165.65. Baxter International Inc. fell$. 14 or. 2 percent, to $72.24. Boston Scientific Corp. fell$. 06 or. 4 percent, to $13.69.

  • Midday Glance: Medical Devices companies Wednesday, 23 Apr 2014 | 1:37 PM ET

    Allergan fell$. 08 or percent, to $163.57. Baxter International Inc. rose$. 07 or. 1 percent, to $72.45. Johnson& Johnson rose$. 19 or. 2 percent, to $100.37.

  • Early Glance: Medical Devices companies Wednesday, 23 Apr 2014 | 10:29 AM ET

    Allergan rose$. 66 or. 4 percent, to $164.31. Baxter International Inc. rose$. 13 or. 2 percent, to $72.51. Boston Scientific Corp. fell$. 05 or. 4 percent, to $13.70.

  • Final Glance: Medical Devices companies Monday, 21 Apr 2014 | 6:02 PM ET

    Allergan rose $8.08 or 6.0 percent, to $142.00. Baxter International Inc. rose$. 34 or. 5 percent, to $73.15. Boston Scientific Corp. rose$. 07 or. 5 percent, to $13.72.

  • Midday Glance: Medical Devices companies Monday, 21 Apr 2014 | 1:20 PM ET

    Allergan rose $3.82 or 2.9 percent, to $137.74. Baxter International Inc. rose$. 35 or. 5 percent, to $73.16. Boston Scientific Corp. fell$. 03 or. 2 percent, to $13.62.

  • Early Glance: Medical Devices companies Monday, 21 Apr 2014 | 10:31 AM ET

    Allergan rose $2.42 or 1.8 percent, to $136.34. Baxter International Inc. rose$. 19 or. 3 percent, to $73.00. Boston Scientific Corp. fell$. 05 or. 3 percent, to $13.61.

  • Final Glance: Medical Devices companies Wednesday, 16 Apr 2014 | 6:02 PM ET

    Allergan rose $3.66 or 2.9 percent, to $131.46. Baxter International Inc. rose$. 09 or. 1 percent, to $73.45. Boston Scientific Corp. rose$. 15 or 1.1 percent, to $13.50.

  • Midday Glance: Medical Devices companies Wednesday, 16 Apr 2014 | 1:30 PM ET

    Allergan rose $3.00 or 2.3 percent, to $130.80. Baxter International Inc. fell$. 04 or. 1 percent, to $73.32. Boston Scientific Corp. rose$. 08 or. 6 percent, to $13.43.

  • Early Glance: Medical Devices companies Wednesday, 16 Apr 2014 | 10:27 AM ET

    Allergan rose $1.18 or. 9 percent, to $128.99. Baxter International Inc. rose$. 51 or. 7 percent, to $73.87. Boston Scientific Corp. rose$. 14 or 1.0 percent, to $13.48.

  • April 15- U.S. health regulators have approved four Boston Scientific Corp implantable devices for heart patients, including a next generation of smaller defibrillators to treat abnormal heart rhythms, the company said on Tuesday.

  • Final Glance: Medical Devices companies Monday, 14 Apr 2014 | 6:01 PM ET

    Allergan rose $3.08 or 2.5 percent, to $123.97. Baxter International Inc. rose$. 78 or 1.1 percent, to $72.76. Boston Scientific Corp. rose$. 62 or 4.9 percent, to $13.31.

  • Midday Glance: Medical Devices companies Monday, 14 Apr 2014 | 2:08 PM ET

    Allergan rose $3.06 or 2.5 percent, to $123.95. Baxter International Inc. rose$. 79 or 1.1 percent, to $72.77. Boston Scientific Corp. rose$. 51 or 4.0 percent, to $13.20.

  • Early Glance: Medical Devices companies Monday, 14 Apr 2014 | 10:21 AM ET

    Allergan rose$. 47 or. 4 percent, to $121.36. Baxter International Inc. rose$. 47 or. 7 percent, to $72.45. Boston Scientific Corp. rose$. 48 or 3.8 percent, to $13.17.

  • Final Glance: Medical Devices companies Friday, 11 Apr 2014 | 6:03 PM ET

    Allergan rose $4.26 or 3.7 percent, to $120.89. Baxter International Inc. fell$. 28 or. 4 percent, to $71.98. Boston Scientific Corp. fell$. 24 or 1.9 percent, to $12.69.

  • Midday Glance: Medical Devices companies Friday, 11 Apr 2014 | 1:51 PM ET

    Allergan rose $4.38 or 3.8 percent, to $121.00. Baxter International Inc. rose$. 15 or. 2 percent, to $72.41. Boston Scientific Corp. fell$. 32 or 2.4 percent, to $12.62.

  • Wall Street analysts had estimated a potential market of $3 billion for the devices made by Medtronic Inc, Boston Scientific Corp and St Jude Medical Inc. But failure of the high-stakes clinical trial set off a heated debate between doctors who believe the approach is worth saving and those who say results show it provides no clear benefit.

  • Feb 18- Medtronic Inc on Tuesday reported a lower quarterly net profit after it took charges for an experimental blood pressure device that failed to prove effective in a clinical study. Medtronic shares fell 2.3 percent to $55.56 in morning trading on the New York Stock Exchange.

  • Feb 18- Medtronic Inc on Tuesday reported lower quarterly net earnings due to charges for the failed clinical study of a treatment being developed for high blood pressure. Excluding the charges and other one-time items, Medtronic earned 91 cents a share, in line with the analysts' average estimate, according to Thomson Reuters I/B/E/S.

  • Feb 4- Medtronic Inc's stumble in its U.S. medical device study to treat high blood pressure could create an opportunity for other device makers to pick up where their rival has left off, Boston Scientific Corp Chief Executive Mike Mahoney said on Tuesday.

  • Feb 4- Boston Scientific Corp on Tuesday reported higher-than-expected quarterly results, citing improving demand for its devices that manage irregular heart rhythms. Boston Scientific is also expected to benefit from the introduction of its S-ICD system.

Most Popular Video

Thursday, 24 Apr 2014 | 8:49 AM ET

Today CNBC's Jim Cramer explains why he wishes his charitable trust owned shares of Caterpillar, and shares his thoughts on the government's inability to create jobs.

Thursday, 24 Apr 2014 | 8:16 AM ET

Daniel Ernst, Hudson Square Research, provides perspective on Apple's earnings and growth potential. Apple is really innovating but they haven't done it in three years, Ernst says.

Thursday, 24 Apr 2014 | 8:02 AM ET

Doug Oberhelman, Caterpillar chairman & CEO, digs deep into the company's first quarter results and shares his outlook on global sales. CAT reported EPS of $1.44 on revenues of $13.24 billion, beating on both the top and bottom line.